Financial Architects (New Jersey)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-14
| Closed | -$2K | – | 1129 |
|
|
2019
Q2 | $2K | Sell |
14
-57
| -80% | -$8.14K | ﹤0.01% | 999 |
|
|
2019
Q1 | $10K | Sell |
71
-6,294
| -99% | -$886K | ﹤0.01% | 980 |
|
|
2018
Q4 | $620K | Buy |
6,365
+6,300
| +9,692% | +$614K | 0.12% | 130 |
|
|
2018
Q3 | $9K | Buy |
65
+11
| +20% | +$1.52K | ﹤0.01% | 1007 |
|
|
2018
Q2 | $7K | Sell |
54
-3,500
| -98% | -$454K | ﹤0.01% | 1080 |
|
|
2018
Q1 | $396K | Buy |
3,554
+3,518
| +9,772% | +$392K | 0.08% | 174 |
|
|
2017
Q4 | $4K | Sell |
36
-90
| -71% | -$10K | ﹤0.01% | 1220 |
|
|
2017
Q3 | $18K | Buy |
126
+100
| +385% | +$14.3K | ﹤0.01% | 887 |
|
|
2017
Q2 | $3K | Sell |
26
-15
| -37% | -$1.73K | ﹤0.01% | 1287 |
|
|
2017
Q1 | $5K | Buy |
41
+9
| +28% | +$1.1K | ﹤0.01% | 1198 |
|
|
2016
Q4 | $4K | Buy |
32
+7
| +28% | +$875 | ﹤0.01% | 1187 |
|
|
2016
Q3 | $3K | Sell |
25
-37
| -60% | -$4.44K | ﹤0.01% | 1250 |
|
|
2016
Q2 | $7K | Sell |
62
-4
| -6% | -$452 | ﹤0.01% | 1044 |
|
|
2016
Q1 | $9K | Buy |
+66
| New | +$9K | ﹤0.01% | 769 |
|
|
2015
Q3 | – | Sell |
-57
| Closed | -$10K | – | 994 |
|
|
2015
Q2 | $10K | Hold |
57
| – | – | ﹤0.01% | 782 |
|
|
2015
Q1 | $10K | Hold |
57
| – | – | ﹤0.01% | 719 |
|
|
2014
Q4 | $11K | Sell |
57
-174
| -75% | -$33.6K | ﹤0.01% | 651 |
|
|
2014
Q3 | $20K | Buy |
231
+174
| +305% | +$15.1K | 0.01% | 473 |
|
|
2014
Q2 | $9K | Buy |
+57
| New | +$9K | ﹤0.01% | 657 |
|